Domenico Gabrielli Selected Research

Domenico Gabrielli Research Topics

Disease

33	Heart Failure 04/2024 - 07/2009
17	Atrial Fibrillation 01/2024 - 05/2012
16	Hemorrhage 01/2024 - 05/2018
13	Cardiovascular Diseases (Cardiovascular Disease) 04/2024 - 08/2020
13	Acute Coronary Syndrome 01/2023 - 05/2018
10	Neoplasms (Cancer) 05/2024 - 01/2021
10	Myocardial Infarction 01/2024 - 11/2019
10	Thrombosis (Thrombus) 06/2023 - 05/2018
9	Stroke (Strokes) 01/2024 - 01/2020
9	Coronary Artery Disease (Coronary Atherosclerosis) 12/2023 - 05/2016
9	COVID-19 02/2022 - 08/2020
8	Chronic Renal Insufficiency 01/2024 - 01/2021
7	Atherosclerosis 01/2024 - 01/2020
6	Venous Thromboembolism 01/2024 - 11/2019
6	Type 2 Diabetes Mellitus (MODY) 04/2023 - 04/2021
5	Hypercholesterolemia 07/2023 - 01/2021
4	Cardiotoxicity 04/2024 - 01/2021
4	Myocarditis (Carditis) 05/2023 - 12/2020
4	Infections 05/2023 - 03/2020
3	Cardiomyopathies (Cardiomyopathy) 04/2024 - 02/2023
3	Thromboembolism 12/2023 - 12/2021
3	Coronary Disease (Coronary Heart Disease) 11/2023 - 03/2023
3	Dyslipidemias (Dyslipidemia) 08/2023 - 10/2020
3	Inflammation (Inflammations) 06/2023 - 01/2022
3	Cardiac Sudden Death (Sudden Cardiac Arrest) 05/2023 - 07/2015
3	Ventricular Tachycardia 05/2023 - 07/2015
2	Heart Valve Diseases (Valvular Heart Disease) 01/2024 - 03/2019
2	Hypertriglyceridemia 12/2023 - 07/2019
2	Fever (Fevers) 10/2023 - 04/2018
2	Cardiac Arrhythmias (Arrythmia) 05/2023 - 05/2023
2	Pulmonary Embolism 04/2023 - 08/2020
2	Left Ventricular Dysfunction 01/2023 - 01/2022
2	Substance-Related Disorders (Drug Abuse) 01/2023 - 06/2022
2	Peripheral Arterial Disease 12/2022 - 11/2019
2	Heart Diseases (Heart Disease) 10/2022 - 10/2019
2	Chest Pain (Chest Pains) 06/2022 - 04/2018
2	Thrombocytopenia (Thrombopenia) 02/2022 - 12/2021
2	Cerebrovascular Disorders (Cerebrovascular Occlusion) 03/2021 - 03/2020
2	Ulcer 03/2021 - 03/2020
1	Sarcopenia 04/2024
1	Second Primary Neoplasms (Neoplasms, Second) 04/2024

Drug/Important Bio-Agent (IBA)

17	AnticoagulantsIBA 05/2024 - 01/2019
10	Glucose (Dextrose)FDA LinkGeneric 03/2023 - 04/2021
8	oxidized low density lipoproteinIBA 12/2023 - 07/2019
8	Sodium-Glucose Transport ProteinsIBA 05/2023 - 05/2022
6	LDL CholesterolIBA 05/2023 - 07/2019
6	LipidsIBA 03/2023 - 07/2019
6	SodiumIBA 10/2022 - 04/2021
5	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 12/2022 - 05/2018
5	SymportersIBA 10/2022 - 08/2021
5	Biomarkers (Surrogate Marker)IBA 10/2021 - 01/2021
4	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 12/2023 - 07/2019
4	dapagliflozinIBA 01/2023 - 08/2021
4	Sodium-Glucose Transporter 2 InhibitorsIBA 01/2023 - 04/2021
4	sacubitril and valsartan sodium hydrate drug combinationIBA 04/2022 - 10/2018
4	2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA 12/2020 - 05/2018
3	vericiguatIBA 04/2024 - 04/2023
3	Vitamin K FDA Link 12/2023 - 01/2020
3	8- hydroxy- 2,2,14,14- tetramethylpentadecanedioic acidIBA 06/2023 - 01/2021
3	Proteins (Proteins, Gene)FDA Link 02/2023 - 12/2021
3	RivaroxabanIBA 12/2022 - 03/2020
3	empagliflozinIBA 05/2022 - 08/2021
3	VaccinesIBA 02/2022 - 12/2021
3	omega-Chloroacetophenone (Mace)IBA 01/2022 - 01/2021
3	Enalapril FDA LinkGeneric 10/2021 - 10/2018
3	CholesterolIBA 04/2021 - 10/2020
2	CytokinesIBA 04/2024 - 01/2022
2	Lipoprotein(a)IBA 01/2024 - 12/2022
2	Uric Acid (Urate)IBA 06/2023 - 01/2022
2	AntibodiesIBA 02/2022 - 12/2021
2	ReninIBA 01/2022 - 04/2021
2	Angiotensin Receptors (Angiotensin II Receptor)IBA 10/2021 - 10/2018
2	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 10/2021 - 01/2019
2	Neprilysin (Neutral Endopeptidase)IBA 10/2021 - 10/2018
2	CanagliflozinIBA 08/2021 - 08/2021
2	ertugliflozinIBA 08/2021 - 08/2021
2	edoxabanIBA 03/2021 - 03/2020
2	Purinergic P2Y Receptor AntagonistsIBA 03/2021 - 03/2020
2	Dabigatran FDA Link 03/2021 - 03/2020
2	Proton Pump InhibitorsIBA 03/2021 - 03/2020
2	Warfarin (Coumadin)FDA LinkGeneric 03/2021 - 03/2020
2	SteroidsIBA 03/2021 - 03/2020
2	trans-crotonin (CTN)IBA 01/2021 - 01/2020
2	PCSK9 InhibitorsIBA 01/2020 - 07/2019
1	AnthracyclinesIBA 04/2024
1	ChemokinesIBA 04/2024
1	Guanylate Cyclase (Guanylyl Cyclase)IBA 04/2024
1	ElectrolytesIBA 01/2024

Therapy/Procedure

43	Therapeutics 05/2024 - 07/2009
15	Percutaneous Coronary Intervention 01/2023 - 05/2018
8	Stents 05/2022 - 05/2018
4	Defibrillators (Defibrillator) 11/2023 - 07/2015
4	Secondary Prevention 01/2023 - 07/2019
3	Catheters 05/2023 - 01/2023
3	Heart-Assist Devices 05/2022 - 01/2022
2	Continuity of Patient Care 01/2023 - 10/2019
2	Heart Transplantation (Grafting, Heart) 05/2022 - 12/2020
2	Inappropriate Prescribing 05/2022 - 12/2021
2	Aftercare (After-Treatment) 10/2021 - 08/2021
1	Telerehabilitation 04/2024